HOJI ALIMI
FOUNDER, CHAIRMAN AND CEO
20 years of experience in the global healthcare industry
Chairman, CEO Ruthigen, Inc.
IPO experience, including raising $170M in capital
FDA and CE approvals of multiple drugs and devices
GREG FRENCH
DIRECTOR, COLLIDION, INC.
Co-owner of G&C Enterprises LLC, a real estate and investment company, which he founded in 1999.
Held various engineering and senior management positions at several medical device companies, including Advanced Cardiovascular Systems, Peripheral Systems Group and Arterial Vascular Engineering. Previously served on the Board of Directors of Oculus Innovative Sciences, Inc. and Ruthigen, Inc.
Jeffrey Castillo
DIRECTOR, COLLIDION, INC.
President, Microsurgical Technologies
V.P. Commercial Operations, Americas, Abbott Medical Optics (AMO)
Johnson & Johnson, Inc., 21 years in a variety of roles including Sales & Marketing Manager for the Infection Control Division, International Business Director for Latin America, Regional Director for Ethicon, Director of US Sales & Marketing for Advanced Sterilization Products
RON CARLI
DIRECTOR, SPECTRUM ANTIMICROBIALS
Former President & CEO, America AgCredit for 32 years
Forged the creation of Agricultural Credit Associations (ACA) by integrating short, intermediate and long-term credit authorities under one umbrella, and negotiated multiple mergers.
Master of Science in Agricultural Science, Cal Poly, Sa Luis Obispo
Ettore CArino
DIRECTOR, COLLDION, INC.
Former Senior Vice President, Johnson & Johnson Medical Devices. Commercial Leader, Americas, Advanced Sterilization Products (ASP).
Over 30 years of Medical Device Industry experience in areas of Sales, Marketing, Product Development, Business Development, and Finance.
Successfully launched and commercially scaled up several innovative medical devices in the areas of General Surgery, Orthopedics, Women’s Health, Urology, and Infection Prevention.
Led the completion of several Public Mergers, Licensing, Co-Development, and Distribution deals at Johnson & Johnson.